Literature DB >> 19723915

Are racial disparities in pancreatic cancer explained by smoking and overweight/obesity?

Lauren D Arnold1, Alpa V Patel, Yan Yan, Eric J Jacobs, Michael J Thun, Eugenia E Calle, Graham A Colditz.   

Abstract

Between 2001 and 2005, Blacks from the United States experienced a 32% higher pancreatic cancer death rate than Whites. Smoking, diabetes, and family history might explain some of this disparity, but prospective analyses are warranted. From 1984 to 2004, there were 6,243 pancreatic cancer deaths among Blacks (n = 48,525) and Whites (n = 1,011,864) in the Cancer Prevention Study II cohort. Multivariate Cox proportional hazards models yielded hazards ratios (HR) for known and suspected risk factors. Population attributable risks were computed and their effect on age-standardized mortality rates were evaluated. Blacks in this cohort had a 42% increased risk of pancreatic cancer mortality compared with Whites (HR, 1.42; 95% confidence intervals (CI), 1.28-1.58). Current smoking increased risk by >60% in both races; although Blacks smoked less intensely, risks were similar to Whites (HR(Black), 1.67; 95% CI, 1.28-2.18; HR(White), 1.82; 95% CI, 1.7-1.95). Obesity was significantly associated with pancreatic cancer mortality in Black men (HR, 1.66; 95% CI, 1.05-2.63), White men (HR, 1.42; 95% CI, 1.25-1.60), and White women (HR, 1.37; 95% CI, 1.22-1.54); results were null in Black women. The population attributable risk due to smoking, family history, diabetes, cholecystectomy, and overweight/obesity was 24.3% in Whites and 21.8% in Blacks. Smoking and overweight/obesity play a substantial a role in pancreatic cancer. Variation in the effect of these factors underscores the need to evaluate disease on the race-sex level. The inability to attribute excess disease in Blacks to currently known risk factors, even when combined with suspected risks, points to yet undetermined factors that play a role in the disease process.

Entities:  

Mesh:

Year:  2009        PMID: 19723915      PMCID: PMC3630792          DOI: 10.1158/1055-9965.EPI-09-0080

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  47 in total

1.  Dietary patterns and risk of pancreatic cancer.

Authors:  André Nkondjock; Daniel Krewski; Kenneth C Johnson; Parviz Ghadirian
Journal:  Int J Cancer       Date:  2005-05-01       Impact factor: 7.396

2.  Dietary patterns and pancreatic cancer risk in men and women.

Authors:  Dominique S Michaud; Halcyon G Skinner; Kana Wu; Frank Hu; Edward Giovannucci; Walter C Willett; Graham A Colditz; Charles S Fuchs
Journal:  J Natl Cancer Inst       Date:  2005-04-06       Impact factor: 13.506

3.  Diabetes mellitus and pancreatic cancer in a population-based case-control study in the San Francisco Bay Area, California.

Authors:  Furong Wang; Samir Gupta; Elizabeth A Holly
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-08       Impact factor: 4.254

4.  Probability of pancreatic cancer following diabetes: a population-based study.

Authors:  Suresh T Chari; Cynthia L Leibson; Kari G Rabe; Jeanine Ransom; Mariza de Andrade; Gloria M Petersen
Journal:  Gastroenterology       Date:  2005-08       Impact factor: 22.682

5.  Racial and ethnic differences in lung cancer incidence: how much is explained by differences in smoking patterns? (United States).

Authors:  Paul F Pinsky
Journal:  Cancer Causes Control       Date:  2006-10       Impact factor: 2.506

6.  Vegetable and fruit intake and pancreatic cancer in a population-based case-control study in the San Francisco bay area.

Authors:  June M Chan; Furong Wang; Elizabeth A Holly
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-09       Impact factor: 4.254

7.  Obesity, recreational physical activity, and risk of pancreatic cancer in a large U.S. Cohort.

Authors:  Alpa V Patel; Carmen Rodriguez; Leslie Bernstein; Ann Chao; Michael J Thun; Eugenia E Calle
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-02       Impact factor: 4.254

8.  Abnormal glucose metabolism and pancreatic cancer mortality.

Authors:  S M Gapstur; P H Gann; W Lowe; K Liu; L Colangelo; A Dyer
Journal:  JAMA       Date:  2000-05-17       Impact factor: 56.272

9.  Insulin, glucose, insulin resistance, and pancreatic cancer in male smokers.

Authors:  Rachael Z Stolzenberg-Solomon; Barry I Graubard; Suresh Chari; Paul Limburg; Philip R Taylor; Jarmo Virtamo; Demetrius Albanes
Journal:  JAMA       Date:  2005-12-14       Impact factor: 56.272

10.  Fruit and vegetable consumption in relation to pancreatic cancer risk: a prospective study.

Authors:  Susanna C Larsson; Niclas Håkansson; Ingmar Näslund; Leif Bergkvist; Alicja Wolk
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-02       Impact factor: 4.254

View more
  51 in total

1.  Pancreatic adenocarcinoma.

Authors:  Margaret A Tempero; J Pablo Arnoletti; Stephen Behrman; Edgar Ben-Josef; Al B Benson; Jordan D Berlin; John L Cameron; Ephraim S Casper; Steven J Cohen; Michelle Duff; Joshua D I Ellenhorn; William G Hawkins; John P Hoffman; Boris W Kuvshinoff; Mokenge P Malafa; Peter Muscarella; Eric K Nakakura; Aaron R Sasson; Sarah P Thayer; Douglas S Tyler; Robert S Warren; Samuel Whiting; Christopher Willett; Robert A Wolff
Journal:  J Natl Compr Canc Netw       Date:  2010-09       Impact factor: 11.908

Review 2.  Cholecystectomy and the risk of alimentary tract cancers: a systematic review.

Authors:  Maria Coats; Sami M Shimi
Journal:  World J Gastroenterol       Date:  2015-03-28       Impact factor: 5.742

Review 3.  Racial Disparity in Gastrointestinal Cancer Risk.

Authors:  Hassan Ashktorab; Sonia S Kupfer; Hassan Brim; John M Carethers
Journal:  Gastroenterology       Date:  2017-08-12       Impact factor: 22.682

Review 4.  Working to Eliminate Cancer Health Disparities from Tobacco: A Review of the National Cancer Institute's Community Networks Program.

Authors:  Elisa K Tong; Pebbles Fagan; Leslie Cooper; Maria Canto; William Carroll; John Foster-Bey; James R Hébert; Maria Lopez-Class; Grace X Ma; Patricia Nez Henderson; Eliseo J Pérez-Stable; LorrieAnn Santos; Justin H Smith; Yin Tan; Janice Tsoh; Kenneth Chu
Journal:  Nicotine Tob Res       Date:  2015-08       Impact factor: 4.244

5.  Oral Health in Relation to Pancreatic Cancer Risk in African American Women.

Authors:  Hanna Gerlovin; Dominique S Michaud; Yvette C Cozier; Julie R Palmer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-03-28       Impact factor: 4.254

6.  Neoadjuvant Therapy in Clinical Stage II Pancreatic Adenocarcinoma.

Authors:  Alexandra Snyder; Peter Allen; Ali Shamseddine; Ali Haydar; Mohamed Eloubeidi; Walid Faraj; Mohamed Khalife; Sally Temraz; Ashwaq El-Olayan; David P Kelsen; Fadi El-Merhi; Mohamed Naghy; Leonard B Saltz; Ghassan K Abou-Alfa; Eileen M O'Reilly
Journal:  Gastrointest Cancer Res       Date:  2012-09

Review 7.  Interplay between smoking-induced genotoxicity and altered signaling in pancreatic carcinogenesis.

Authors:  Navneet Momi; Sukhwinder Kaur; Moorthy P Ponnusamy; Sushil Kumar; Uwe A Wittel; Surinder K Batra
Journal:  Carcinogenesis       Date:  2012-05-23       Impact factor: 4.944

8.  Pancreatic Cancer Incidence, Mortality, and Survival in Puerto Rico, 2001-2015.

Authors:  M Castañeda-Avila; C R Torres-Cintrón; A Cruz-Benítez; W Fuentes-Payán; A Maldonado-Albertorio; L Nieves-Ferrer; P Padró-Juarbe; R Soto-Abreu; N Perez-Ríos; K J Ortiz-Ortiz; P Magno; A P Ortiz
Journal:  P R Health Sci J       Date:  2019-09       Impact factor: 0.705

9.  CDKN2A Germline Rare Coding Variants and Risk of Pancreatic Cancer in Minority Populations.

Authors:  Robert R McWilliams; Eric D Wieben; Kari G Chaffee; Samuel O Antwi; Leon Raskin; Olufunmilayo I Olopade; Donghui Li; W Edward Highsmith; Gerardo Colon-Otero; Lauren G Khanna; Jennifer B Permuth; Janet E Olson; Harold Frucht; Jeanine Genkinger; Wei Zheng; William J Blot; Lang Wu; Luciana L Almada; Martin E Fernandez-Zapico; Hugues Sicotte; Katrina S Pedersen; Gloria M Petersen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-07-23       Impact factor: 4.254

10.  Outcomes in Patients With Metastatic Pancreatic Adenocarcinoma With the Introduction of New Chemotherapeutic Drugs: 10-Year Experience of a Single NCI-designated Comprehensive Cancer Center.

Authors:  Kevin J Zhang; Greg Dyson; Joshua L Gatz; Michael E Silverman; Anteneh A Tesfaye; Anthony F Shields; Philip A Philip
Journal:  Am J Clin Oncol       Date:  2019-03       Impact factor: 2.339

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.